Spectrum Pharma Inc (SPPI) 6.70 $SPPI Biotechnology

New Post Public Reply Private Reply Replies (0) Message Board

Jul 11, 2016 at 10:08 PM

Spectrum Pharma Inc (SPPI) 6.70 $SPPI

Biotechnology Stocks Under the Scanner -- PTC Therapeutics, Inovio Pharma, VIVUS, and Spectrum Pharma
PR Newswire - Mon Jul 11, 7:23AM CDT
On Friday, July 08, 2016, the NASDAQ Composite ended the trading session at 4,956.76, up 1.64%; the Dow Jones Industrial Average advanced 1.40%, to finish at 18,146.74; and the S&P 500 closed at 2,129.90, up 1.53%. The gains were broad based as all the sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: PTC Therapeutics Inc. (NASDAQ: PTCT), Inovio Pharmaceuticals Inc. (NASDAQ: INO), VIVUS Inc. (NASDAQ: VVUS), and Spectrum Pharmaceuticals Inc. (NASDAQ: SPPI). Learn more about these stocks by accessing their free notes at:
INO: 9.12 (+0.01), VVUS: 1.14 (-0.04), PTCT: 7.47 (-0.06), SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals Has Returned 27.2% Since SmarTrend Recommendation (SPPI)
Comtex SmarTrend(R) - Thu Jul 07, 12:41AM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 4 months, Spectrum Pharmaceuticals has returned 27.15% as of today's recent price of $6.79.
SPPI: 6.70 (-0.05)

Forget Valeant, Invest in These Attractive Drug Stocks Instead
Zacks Equity Research - Zacks Investment Research - Tue Jun 28, 2:52PM CDT
It's probably best to forget Valeant and instead invest in some other drug stocks with a favorable Zacks Rank.
VRX: 23.09 (-0.16), OGXI: 0.96 (-0.06), CPRX: 0.80 (unch), ARQL: 1.71 (-0.03), SPPI: 6.70 (-0.05)

Uptrend Call Working As Spectrum Pharmaceuticals Stock Rises 26.0% (SPPI)
Comtex SmarTrend(R) - Tue Jun 21, 1:34PM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 3 months, Spectrum Pharmaceuticals has returned 26.03% as of today's recent price of $6.73.
SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals Up 28.7% Since SmarTrend Uptrend Call (SPPI)
Comtex SmarTrend(R) - Tue Jun 14, 12:59AM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 3 months, Spectrum Pharmaceuticals has returned 28.65% as of today's recent price of $6.87.
SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals Up 35.6% Since SmarTrend Uptrend Call (SPPI)
Comtex SmarTrend(R) - Mon Jun 06, 1:27PM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 3 months, Spectrum Pharmaceuticals has returned 35.58% as of today's recent price of $7.24.
SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals to Present Corporate Update at the Jefferies 2016 Healthcare Conference on June 8th
BusinessWire - Wed Jun 01, 6:00AM CDT
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, today announced that an overview of the Company's business strategy and commercial and development-stage programs will be given at the Jefferies 2016 Healthcare Conference being held at the Grand Hyatt in New York. The Company presentation is on Wednesday, June 8, 2016, at 10:30 AM ET.
SPPI: 6.70 (-0.05)

Uptrend Call Working As Spectrum Pharmaceuticals Stock Rises 39.1% (SPPI)
Comtex SmarTrend(R) - Fri May 27, 1:06PM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 3 months, Spectrum Pharmaceuticals has returned 39.14% as of today's recent price of $7.43.
SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals Shares Up 33.0% Since SmarTrend's Buy Recommendation (SPPI)
Comtex SmarTrend(R) - Thu May 12, 1:09PM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 2 months, Spectrum Pharmaceuticals has returned 32.96% as of today's recent price of $7.10.
SPPI: 6.70 (-0.05)

Spectrum Pharma reports 1Q loss
Automated Insights - Thu May 05, 3:25PM CDT
HENDERSON, Nev. (AP) _ Spectrum Pharmaceuticals Inc. (SPPI) on Thursday reported a loss of $9.3 million in its first quarter.
SPPI: 6.70 (-0.05)

Spectrum Pharmaceuticals Reports First Quarter 2016 Financial Results and Pipeline Update
BusinessWire - Thu May 05, 3:00PM CDT
--Poziotinib, a novel pan-HER inhibitor: A Phase 2 trial was initiated and is enrolling breast cancer patients who have failed other HER2-directed therapies.
SPPI: 6.70 (-0.05)

30.3% Return Seen to Date on SmarTrend Spectrum Pharmaceuticals Call (SPPI)
Comtex SmarTrend(R) - Thu May 05, 12:49AM CDT
SmarTrend identified an Uptrend for Spectrum Pharmaceuticals (NASDAQ:SPPI) on March 10th, 2016 at $5.34. In approximately 2 months, Spectrum Pharmaceuticals has returned 30.34% as of today's recent price of $6.96.
SPPI: 6.70 (-0.05)

Ligand (LGND) Q1 Earnings: What's in Store for the Stock?
Arpita Dutt - Zacks Investment Research - Mon May 02, 10:09AM CDT
Will Ligand (LGND) pull a surprise and surpass expectations in the first quarter as well?
LGND: 126.76 (+0.90), SPPI: 6.70 (-0.05), BIND: 0.53 (-0.03), FOLD: 5.91 (-0.09)

FDA Grants Orphan Drug Exclusivity to EVOMELA(TM) (melphalan) for Injection, Indicated for Multiple Myeloma
BusinessWire - Wed Apr 20, 6:00AM CDT
Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in Hematology and Oncology, announced today that the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) has granted 7 years of Orphan Drug Exclusivity for EVOMELA for use as a high-dose conditioning treatment prior to hematopoietic progenitor (stem) cell transplantation in patients with multiple myeloma. EVOMELA has also been recently listed in the Orange Book, including two composition of matter patents that do not expire until March 2029.
SPPI: 6.70 (-0.05)

Four Biotech Stocks To Consider As The Sector Breaks Out
ACCESSWIRE - Thu Apr 07, 11:57AM CDT
NEW YORK, NY / ACCESSWIRE / April 7, 2016 / Has biotech finally bottomed? After an 8-month long bear market with biotech stocks losing over 40%, signs of a breakout are now becoming more and more obvious. All eyes are on the iShares NASDAQ Biotechnology Index ETF (NASDAQ:IBB) as the 50 day moving average has been overtaken since the beginning of the month.
VRX: 23.09 (-0.16), CRBP: 3.26 (+0.27), IBB: 270.56 (-0.57), SPPI: 6.70 (-0.05)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

iScooter's Bold Black Friday Launch Targets All Ages

Revving Up for Black Friday Scootering Alright folks, we're diving headfirst into iScooter's ambitious 2026 Black Friday campaign, and boy, it’s packed to the rafters. Running from October 20 to November 30, they're littering the market with discounts, sparking the interest of adults and kids alike with their electric two-wheelers. Not just another Holiday marketing...

Barco, VUE Partner to Elevate German Cinemas

Alright, cinema tech enthusiasts, gather up. Remember when going to the movies was just about the popcorn and hoping the ticket lines were short? Now we're witnessing cinema transform into an all-out tech arena, and that’s where Barco and VUE come into play. It seems these folks have decided the German film scene deserves a makeover. Yep, we're talking about pimping out...

CGTN Introduces AI-Driven News Pal for Global Views

News Pal: A New Spin on Global Reporting Folks in the newsroom are buzzing about CGTN’s fresh-faced brainchild, News Pal. This isn’t your run-of-the-mill news brief; we’re talking about a web-based AI contraption that’s flipping the script on how we digest the heap of headlines thrown at us every day. Launched mid-October, News Pal’s in the business of...

Endeavour and Trevi Turn Data Centers Into Water Sources

Turning Data Centers Into Wells If you'd told me data centers could double as water sources, I'd have laughed you off. But this week brings us a game-changing partnership between Endeavour and Trevi Systems. They're using the waste heat from data centers to create clean water, tackling water scarcity in the process. Imagine this: for every megawatt of computing power, up...

Podium Surges Past $150M in AI ARR Milestone

A New Era for Podium When the brass at Podium made a gamble on AI, they didn't just try squeezing it into their old business model. Oh no, they launched what feels like a startup within their existing empire—no half-measures, just full-throttle ambition. Fast forward two and a half years, and they've racked up over $150 million in annual recurring revenue from these...

AHN Launches Cancer Screenings at Work; Dollar Bank First

Pioneering Workplace Cancer Screening Initiative In a move that could redefine preventive healthcare, Allegheny Health Network (AHN) Cancer Center is taking cancer screenings right to the workplace. This initiative isn't just a new gimmick—it's a smart pivot in delivering healthcare where it's most convenient for employees. Here's looking at you, Dollar Bank, for being...

Tierra Encantada Expands Into North Carolina Market

Tierra Encantada is making its way down to the Tar Heel State, bringing its Spanish Immersion Early Education® program to the thriving community of Raleigh. Talk about catching the right wave at the right time. With a burgeoning demand for quality early education in fast-growing markets, Tierra Encantada's expansion into North Carolina seems like a no-brainer. Raleigh:...

Union Alarmtronic Joins Forces with Pye-Barker in Key Sale

A Key Merger in Security Sector Here's a deal that's got the market talking: Union Alarmtronic, a stalwart in the security systems arena, has tied the knot with Pye-Barker Fire & Safety, one of the biggest names in fire protection and life safety. This move isn't just another line in the 'mergers & acquisitions' logbook; it's a strategic shift that underscores the growing...

LianLian and PayPal: Transforming Creator Payouts Globally

Social Commerce Meets Seamless Payments Ah, the sweet smell of global payments getting a makeover—it’s about time! LianLian Global's new dance with PayPal (NASDAQ:PYPL) is turning heads, pushing boundaries, and setting an entirely new stage for the gig economy. With LianLian’s clients now able to zap payments directly into PayPal and Venmo accounts, creators and...

Chery's TIGGO7 Crash Test Sparks Family Safety Confidence

Safety Is More Than a Buzzword for CHERY In the world of automobile mayhem, CHERY's "Guardian. For Family" event threw down the gauntlet, showing they ain't just playing with fire—they're harnessing it for family safety. Now, over in Longshan Crash Laboratory in Wuhu, we got to see the TIGGO7 take a 50 km/h head-on collision with a truck. Yeah, it's as dramatic as it...